Eric J Rubin1. Show Affiliations » 1. From the Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston.
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/therapeutic useHumansIsoniazid/therapeutic useMaleMiningTuberculosis/prevention & control
Substances: See more » Antitubercular AgentsIsoniazid
Year: 2014 PMID: 24450896 DOI: 10.1056/NEJMe1312301
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245